Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges

According to data provided by World Health Organization, hepatocellular carcinoma (HCC) is the sixth most common cause of deaths due to cancer worldwide. Tremendous progress has been achieved over the last 10 years developing novel agents for HCC treatment, including small-molecule kinase inhibitors...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Monica A. Kamal, Yasmine M. Mandour, Mostafa K. Abd El-Aziz, Ulrike Stein, Hend M. El Tayebi
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2022-08-01
Serier:	Molecules
Fag:	small molecule inhibitors growth factor receptors inhibitors tyrosine kinase inhibitors hepatocellular carcinoma molecular targets small molecules as immunomodulators
Online adgang:	https://www.mdpi.com/1420-3049/27/17/5537
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!